Key result
The coexistence of a mechanical heart valve requiring permanent anticoagulation and severe primary immune thrombocytopenia poses a major risk for fatal bleeding complications.
Why the study?
The coexistence of mechanical heart valves requiring anticoagulation with severe thrombocytopenia creates a high bleeding risk and potential fatal complications.
Case Report (n=1)
No
The coexistence of a mechanical heart valve requiring anticoagulation and severe autoimmune thrombocytopenia creates a highly challenging clinical scenario with a high risk of fatal bleeding complications.
Answers are grounded in this paper and cite their sources.
Additional bleeding risk in ITP with mechanical valves warrants caution; leaves open optimal anticoagulation strategies.
and is clinically manifested through signs and symptoms such as bleeding, ecchymosis and petechiae. Its coexistence with the implantation of the mechanical valves and the necessity of anticoagulation creates an additional risk of bleeding. Although mechanical valves are indispensable in prolonging and improving the quality of life in patients with valvular heart disease, in the context of an additional bleeding risk factor, their presence could represent a threat to life exposing the patient to major complications and leading to death. The purpose of this case report is to discuss the disadvantages and possible fatal complications of the association between mechanical valves and severe thrombocytopenia. A possible solution to these downsides could be found in the future search in regenerative medicine and tissue engineering of heart valves resulting in products that do not require anticoagulation and do not pose a threat to patients with thrombocytopenia.
No takes yet. Share an insight, caveat, or question.
Movileanu et al. (2020) conducted a case report in Primary immune thrombocytopenia and mechanical heart valve (n=1). Mechanical heart valve and oral anticoagulation with concurrent severe thrombocytopenia was evaluated. The coexistence of a mechanical heart valve requiring permanent anticoagulation and severe primary immune thrombocytopenia poses a major risk for fatal bleeding complications.
Synapse has enriched 10 related papers. Consider them for comparative context: